Clinical Trial

Investigating Health Impacts of Exposure to Harmful Algal Blooms

Recruiting
View on ClinicalTrials.gov →
Summary
The goals of this project are to study the biological effects of environmental toxins (ET), in particular aquatic toxins such as brevetoxins (PbTx) and microcystin or their metabolites. This study is designed to examine the effects of the body from harmful algae blooms (HAB) as well as possibility of an association between exposure to the marine toxin, brevetoxin (PbTx), which is released from K. brevis during the red tide bloom, and the prevalence of neurological illnesses.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-03-12.
Trial Details
NCT Number NCT06883227
Lead Sponsor Roskamp Institute Inc.
Conditions Red Tide, Neurologic Disorder, Florida
Enrollment 400 participants
Start Date 2024-10-14
Primary Completion 2029-10-14 (estimated)
Study Completion 2030-10-14 (estimated)
Updated on ClinicalTrials.gov 2025-03-24